Katherine Shapiro

Disclosure information not submitted.

Presentation(s):

• MP19-06: Antibiotic Use, Best Practice Statement Adherence, and UTI Rate for Intradetrusor Onabotulinumtoxin A Injection for Overactive Bladder: A Multi-Institutional Collaboration from the SUFU Research Network

  Friday, April 28, 2023
  3:30 PM – 5:30 PM CST

• MP19-14: Who Receives Third Line Therapies for Overactive Bladder? Trends from Data in the AUA AQUA Registry

  Friday, April 28, 2023
  3:30 PM – 5:30 PM CST